secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2022-01-03T23:59:59+00:00
Accession:  0001213900-22-000118
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband receives Korean patent for abuse-deterrent transdermal system AVERSA
------------------------------------------------------------------------------

- Korean Intellectual Property Office issued full patent titled 'Abuse and Misuse Deterrent Transdermal System'.
- Patent supports 4p Therapeutics' AVERSA fentanyl transdermal system using taste aversion.
- Company previously received notice of allowance in December 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022000118/0001213900-22-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022000118/ea153351-8k_nutribandinc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer